An Expedient and Short Synthesis of a 6-Iodo Isocoumarin Building Block for the Rubromycin Family and its First Palladium-Catalyzed Couplings

Synlett ◽  
2004 ◽  
Vol 2004 (15) ◽  
pp. 2736-2738 ◽  
Author(s):  
Hans-Ulrich Reissig ◽  
Malte Brasholz
2012 ◽  
Vol 7 (7) ◽  
pp. 1691-1696 ◽  
Author(s):  
Shaoyu Li ◽  
Yong Luo ◽  
Xiaocong Wang ◽  
Minjie Guo ◽  
Jie Wu

2021 ◽  
Author(s):  
Michael R. Reynolds ◽  
Sabrina Piazza ◽  
Jonathan Chiaramonte ◽  
Fabiola A. Chapa-Villarreal ◽  
John Trant

The total synthesis of the Thomsen-nouveau (Tn) antigen, a tumour-associated O-linked mucin glycopeptide, was achieved through a concise route. The key glycosylation step proved challenging to reproduce from the literature precedents and was most reliably accomplished using a palladium-catalyzed coupling between the glycosyl donor and Fmoc-functionalized serine acceptor to form the target in moderate yields. This is, to the best of our knowledge, the shortest synthesis reported from galactose for preparing this essential building block for large-scale solid phase peptide synthesis.


Synlett ◽  
2017 ◽  
Vol 29 (01) ◽  
pp. 121-125 ◽  
Author(s):  
Andreas Kirschning ◽  
Heiko Sommer ◽  
Max Braun ◽  
Benjamin Schröder

4-Ethoxy-1,1,1-trifluoro-3-buten-2-one (ETFBO) serves as a trifluoromethyl-containing building block for the preparation of trifluoromethyl-substituted thiophenes, furans, pyrrols, and piperazines. Key steps are an addition–elimination reaction to ETFBO followed by the thiazolium-catalyzed Stetter reaction. The scope of this chemistry was demonstrated in a new synthetic approach towards the COX-2 selective, nonsteroidal anti-inflammatory drug Celebrex® (celecoxib).


Sign in / Sign up

Export Citation Format

Share Document